生长素
生长激素促分泌素受体
神经科学
疾病
受体
痴呆
激素
神经退行性变
医学
内科学
内分泌学
心理学
作者
Jing Tian,Tienju Wang,Heng Du
标识
DOI:10.1016/j.conb.2022.102655
摘要
Alzheimer's disease (AD) is the most common type of dementia in seniors. Current efforts to understand the etiopathogenesis of this neurodegenerative disorder have brought forth questions about systemic factors in the development of AD. Ghrelin is a brain-gut peptide that is activated by ghrelin O-acyltransferase (GOAT) and signals via its receptor, growth hormone secretagogue receptor (GHSR). With increasing recognition of the neurotropic effects of ghrelin, the role of ghrelin system deregulation in the development of AD has been accentuated in recent years. In this review, we summarized recent research progress regarding the mechanisms of ghrelin signaling dysregulation and its contribution to AD brain pathology. In addition, we also discussed the therapeutic potential of strategies targeting ghrelin signaling for the treatment of this neurological disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI